ASPIRIN
- Product NDC
- 49483-011
- 11-digit product format
- 494830011
- Labeler code
- 49483
- Product ID
- 49483-011_0acac93d-0f05-0658-e063-6294a90a83c3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ASPIRIN
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- TIME CAP LABS INC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-02
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 49483-011-00 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 49483-011-10 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 49483-011-01 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 49483-011-00 | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 49483-011-10 | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 49483-011-01 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ASPIRIN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 212033 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fe12519c-3e5f-4592-bd34-2d6b81b981f4 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 49483-011-00 | 2021-11-22 | Aspirin 325 mg tablets |
| 49483-011-01 | 2021-11-22 | Aspirin 325 mg tablets |
| 49483-011-10 | 2021-11-22 | Aspirin 325 mg tablets |
| 49483-011-00 | 2020-01-31 | Aspirin 325 mg tablets |
| 49483-011-01 | 2020-01-31 | Aspirin 325 mg tablets |
| 49483-011-10 | 2020-01-31 | Aspirin 325 mg tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49483-011-00 | ASPIRIN | 100000 in 1 CARTON | TABLET, COATED | 100000 | 4 | |
| 49483-011-01 | ASPIRIN | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 4 | |
| 49483-011-10 | ASPIRIN | 1000 in 1 BOTTLE, PLASTIC | TABLET, COATED | 1000 | 4 | |
| 49483-011-31 | ASPIRIN | 300 in 1 BOTTLE | TABLET, COATED | 300 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-011-01 | EA - Each | 49483-011 | 1a8b4a59-e054-44a3-8315-d49574cf89e3 | 1 | 2012-07-24 |
| 49483-011-10 | EA - Each | 49483-011 | d996d20c-42cd-41a2-a29a-679d7f395c76 | 1 | 2014-05-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acetaminophen pm extra strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Sam's West Inc | cff9a730-2241-4e4c-bf6b-a2fa895e2417 | 2026-09-03 | Warnings | M013 |
| GOODYS MAX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 02b3a604-3f09-47e7-add1-b9038b3a268b | 2026-09-03 | Warnings | M013 |
| infants pain and fever | ACETAMINOPHEN | CVS Pharmacy | 53b06c48-598e-41ad-ac7a-5508c195535c | 2026-09-03 | Warnings | M013 |
| Aspirin Regular Strength | ASPIRIN | Cardinal Health 110, LLC. DBA Leader | 2777beea-06d7-4ff5-ae4a-ad7a117dfb62 | 2026-09-02 | Warnings | M013 |
| AMAZON BASIC CARE ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 113d92bf-f6c9-cc3d-e063-6294a90af033 | 2026-09-02 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | Shield Pharmaceuticals Corp. | 78052120-40d8-4a3f-b72f-cc78ca76213b | 2026-09-02 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | NuCare Pharmaceuticals,Inc. | fd199a7f-76ca-fefc-e053-6294a90a821d | 2026-09-02 | Warnings | M013 |
| Adult Low Dose Chewable Aspirin | ASPIRIN | Farmacias De Similares TX LLC | 513ea306-74c6-96e3-e063-6394a90a8262 | 2026-09-01 | Warnings | M013 |
| Kroger Children Pain plus Fever chewables | ACETAMINOPHEN | KROGER COMPANY | 83b5733c-70a1-4383-9729-2eb896d0149a | 2026-09-01 | Warnings | M013 |
| childrens acetaminophen | ACETAMINOPHEN | United Natural Foods, Inc. dba UNFI | f4642725-f953-4aa8-8106-f468d8220f65 | 2026-09-01 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | TOP CARE (Topco Associates LLC) | 923b443d-73cc-4c52-92e4-a075786b1ae3 | 2026-09-01 | Warnings | M013 |
| ACETAMINOPHEN PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Amazon.com Services LLC | 99a137d6-07eb-43bc-b4b4-1a23041d595e | 2026-08-31 | Warnings | M013 |
| MAX relief junior Grape | CHILDRENS ACETAMINOPHEN | Akron Pharma Inc. | cc769c26-556a-4831-bd75-61a7383aa707 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | CHILDRENS ACETAMINOPHEN | Akron Pharma Inc. | ebb3b4ba-2d0b-48d9-b6ee-6d4696aea047 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | ACETAMINOPHEN | Akron Pharma Inc. | 0e43b885-3843-4f11-9a53-02a38c228313 | 2026-08-31 | Warnings | M013 |
| MAX relief junior | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | d7874e4d-0b38-4bb1-9a62-aa4f66d9baf9 | 2026-08-31 | Warnings | M013 |
| MAX relief junior Grape | CHILDREN ACETAMINOPHEN | Akron Pharma Inc. | 3c7a7f40-4963-4fd1-942e-93fa08a45830 | 2026-08-31 | Warnings | M013 |
| Genexa Kids Pain and Fever | ACETAMINOPHEN | Genexa Inc. | 5a615118-33c9-1520-e063-6394a90a21a6 | 2026-08-31 | Warnings | M013 |
| acetaminophen extra strength | ACETAMINOPHEN | Sam's West Inc | dd99efd0-4ca4-4dc6-a940-bebd17ac8f8d | 2026-08-28 | Warnings | M013 |
| Medline | ACETAMINOPHEN | Medline Industries, LP | 4b0cc37c-56ce-6a73-e063-6394a90a80a3 | 2026-08-28 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 4 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 4 |
| 212033 | ASA 325 MG Oral Tablet | SY | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 4 |
| 212033 | aspirin 325 MG Oral Tablet | PSN | 01cdc525-f51f-4779-9e3b-01a35dd3bcac | 2 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 01cdc525-f51f-4779-9e3b-01a35dd3bcac | 2 |
| 212033 | ASA 325 MG Oral Tablet | SY | 01cdc525-f51f-4779-9e3b-01a35dd3bcac | 2 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | PSN | 2d368df5-c176-435d-b8b9-a171f972fd14 | 1 |
| 198467 | aspirin 325 MG Delayed Release Oral Tablet | SCD | 2d368df5-c176-435d-b8b9-a171f972fd14 | 1 |
| 198467 | ASA 325 MG Delayed Release Oral Tablet | SY | 2d368df5-c176-435d-b8b9-a171f972fd14 | 1 |
| 198467 | aspirin 325 MG Enteric Coated Oral Tablet | SY | 2d368df5-c176-435d-b8b9-a171f972fd14 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 49483-011-00 | 49483001100 | 100000 TABLET, COATED in 1 CARTON (49483-011-00) | 2014-04-02 | 0000-00-00 | No | No | Current |
| 49483-011-01 | 49483001101 | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (49483-011-01) | 2014-04-02 | 0000-00-00 | No | No | Current |
| 49483-011-10 | 49483001110 | 1000 TABLET, COATED in 1 BOTTLE, PLASTIC (49483-011-10) | 2014-04-02 | 0000-00-00 | No | No | Current |
| 49483-011-31 | 49483001131 | 300 TABLET, COATED in 1 BOTTLE (49483-011-31) | 2023-11-02 | No | No | Current |